# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a In-Line and raises the price target f...
Edwards Lifesciences (NYSE:EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes ...
BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash....
Critical Care has approximately 4,500 employees with most based in Irvine, California. In 2023, the business generated more tha...